FrancophonIA/ELRC3.0 huggingface dataset:
English: It prevents death and symptoms of the disease and reduces the shedding of the virus.
Estonian: Sellega välditakse haigusest tingitud suremust ja sümptomeid ning vähendatakse viiruse eritumist.
English: Female breeding pigs should be revaccinated before their first mating or during each pregnancy, three to six weeks before giving birth.
Estonian: Aretusemiseid tuleb revaktsineerida enne esimest paaritamist või iga tiinuse ajal, kolm kuni kuus nädalat enne poegimist.
English: Wash and disinfect hands and equipment after use.
Estonian: Pärast kasutamist peske ja desinfitseerige käed ja vahendid.
English: The antibodies are also passed on from mother to piglet through the colostrums (first milk) and milk.
Estonian: Antikehad kanduvad emiselt põrsale ka ternespiima (esimene piim) ja piima kaudu.
English: An increase in body temperature up to about 40.5°C can occur in a small number of pigs, lasting for up to two days.
Estonian: Vähestel sigadel võib kehatemperatuur tõusta ligikaudu 40,5 °C-ni, mis püsib kuni kaks päeva.
English: This protects the pigs against the disease.
Estonian: See kaitseb sigu haiguse vastu.
English: The vaccine also contains ‘adjuvants' (a compound containing aluminium as well as mineral oil, an emulsifier and a detergent) to stimulate a better response.
Estonian: Vaktsiin sisaldab parema ravivastuse stimuleerimiseks ka adjuvante (alumiiniumiühendit, samuti mineraalõli, emulgaatorit ja detergenti).
English: Accidental injection can cause severe pain and swelling, particularly if the vaccine is injected into a joint or finger.
Estonian: Vaktsiini juhuslik iseendale süstimine võib põhjustada tugevat valu ja turset, eriti kui seda süstida liigesesse või sõrme.
English: The studies compared the levels of infection in vaccinated and unvaccinated pigs.
Estonian: Uuringutes võrreldi nakatumise taset vaktsineeritud ja vaktsineerimata sigade seas.
English: When a pig is given the vaccine, the immune system recognises the weakened viruses as ‘foreign' and makes antibodies against them.
Estonian: Kui seale antakse vaktsiini, peab immuunsüsteem nõrgestatud viirusi "võõrasteks" ja produtseerib nende vastu antikehi.
English: Breeding boars (male pigs) should be revaccinated every six months.
Estonian: Aretuskulte (isasloomi) tuleb revaktsineerida iga kuue kuu järel.
English: After vaccination, the number of pig herds with signs of infection fell significantly, as did the number of infected pigs within the herds.
Estonian: Pärast vaktsineerimist vähenes oluliselt nakkusenähtudega seakarjade arv ning nakatunud sigade arv karjades.
English: Live attenuated Aujeszky's Disease Virus
Estonian: Aujeszky haiguse elus nõrgestatud viirus
English: To vaccinate a whole herd, one dose should be given to every male and female breeding pig every four months.
Estonian: Kogu karja vaktsineerimiseks manustatakse igale aretusemisele ja -kuldile üks annus iga nelja kuu järel.
English: In case of accidental injection, seek prompt medical advice and show the Package Leaflet to the doctor.
Estonian: Juhusliku iseenesele süstimise korral pöörduge kohe arsti poole ja näidake talle pakendi infolehte.
English: The virus has been genetically modified: it has had one of its gene deleted (the gene that makes it able to produce an enzyme called thymidine kinase) and this is what makes it weaker.
Estonian: Viirust on geneetiliselt modifitseeritud: selles on üks (ensüümi tümidiinkinaasi produtseerimist võimaldav) geen deleteeritud, mis nõrgestabki viirust.
English: In up to a half of pigs being vaccinated, a slight temporary reaction can occur at the site of injection.
Estonian: Kuni pooltel vaktsineeritud sigadel võib tekkida süstekohal kerge mööduv reaktsioon.
English: This enables the piglets of vaccinated pigs to be protected against the disease.
Estonian: See võimaldab kaitsta vaktsineeritud sigade põrsaid haiguse vastu.
English: In the future, the immune system will be able to produce antibodies more quickly when it is again exposed to the viruses.
Estonian: Kui siis immuunsüsteem uuesti viirustega kokku puutub, on see võimeline antikehi kiiremini produtseerima.
English: What is the withdrawal period?
Estonian: Keeluaeg on null päeva.
English: The effectiveness of Suvaxyn Aujeszky 783 + O/W has been studied in a large number of pigs in several farms in studies lasting around two years.
Estonian: Suvaxyn Aujeszky 783 + O/W efektiivsust uuriti mitme põllumajandusettevõtte paljudel sigadel uuringutes, mis kestsid ligikaudu kaks aastat.
English: There was no change in the infection rates in the pigs that were not vaccinated.
Estonian: Vaktsineerimata sigade nakatumismäärad ei muutunud.
English: The benefit/risk balance may be found in the scientific discussion module of this EPAR.
Estonian: Ravimi kasulikkuse ja riski suhte leiate käesoleva Euroopa avaliku hindamisaruande 6. jaotisest.
English: Suvaxyn Aujeszky 783 + O/W is used to vaccinate pigs from the age of 10 weeks against Aujeszky's disease, an illness similar to rabies that is caused by a herpesvirus.
Estonian: Suvaxyn Aujeszky 783 + O/W-d kasutatakse vähemalt 10 nädala vanuste sigade vaktsineerimiseks Aujeszky haiguse vastu, mis on marutaudi sarnane herpesviirusest põhjustatud haigus.
English: The withdrawal period is the time allowed after administration of the medicine and before the animal can be slaughtered and the meat used for human consumption or eggs or milk used for human consumption.
Estonian: Kui palju aega peab mööduma, kuni looma võib tappa ja tema liha toiduks tarvitada (keeluaeg)?
English: Vaccination of gilts (female pigs that have not yet had piglets) and sows (female pigs that have had piglets before) with Suvaxyn Aujeszky 783 + O/W can also result in immunity in the pig's offspring.
Estonian: Nooremiste (veel poegimata emised) ja emiste (poeginud emasloomad) vaktsineerimisega Suvaxyn Aujeszky 783 + O/W-ga võidakse saavutada ka emise põrsaste immuunsus.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Suvaxyn Aujeszky 783 + O/W on 7 August 1998.
Estonian: Euroopa Komisjon väljastas Suvaxyn Aujeszky 783 + O/W müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 7. augustil 1998.
English: Suvaxyn Aujeszky 783 + O/W is given as two 2 ml injections into the muscle of the neck behind the ear, three to four weeks apart.
Estonian: Suvaxyn Aujeszky 783 + O/W-d manustatakse kahe 2 ml süstina kolme- kuni neljanädalase intervalliga kõrva taha kaelalihasesse.
English: Passive immunisation of the progeny of vaccinated gilts and sows to reduce mortality and clinical signs of Aujeszky's Disease and to reduce the excretion of Aujeszky's Disease field virus, and recommended that Suvaxyn Aujeszky 783 + O/W be given a marketing authorisation.
Estonian: Veterinaarravimite komitee otsustas, et Suvaxyn Aujeszky 783 + O/W kasulikkus sigade aktiivseks ja passiivseks immuniseerimiseks, et vältida Aujeszky haigusest tingitud suremust ja kliinilisi tunnuseid ning vähendada Aujeszky haiguse välitingimustes esineva viiruse eritumist, on suurem kui sellega kaasnevad ohud, ning soovitas anda Suvaxyn Aujeszky 783 + O/W-le müügiloa.
English: The herds of pigs were monitored for signs of infection with the type of Aujeszky's disease virus that is can be caught in the field.
Estonian: Seakarju jälgiti välitingimustes esineva Aujeszky haiguse tüübiga nakatumise nähtude suhtes.
English: Suvaxyn Aujeszky 783 + O/W is a vaccine that contains a live attenuated (weakened) form of Aujeszky's disease virus strain NIA3-783.
Estonian: Suvaxyn Aujeszky 783 + O/W on vaktsiin, mis sisaldab Aujeszky haiguse elusa viirusetüve NIA3-783 t nõrgestatud vormi.
English: Suvaxyn Aujeszky 783 + O/W is a vaccine.
Estonian: Suvaxyn Aujeszky 783 + O/W on vaktsiin.
English: Suvaxyn Aujeszky 783 + O/W contains small amounts of a weakened form of the virus that causes Aujeszky's disease.
Estonian: Suvaxyn Aujeszky 783 + O/W sisaldab väheses koguses Aujeszky haigust põhjustava viiruse nõrgestatud vormi.
English: Suvaxyn Aujeszky 783 + O/W is a powder and solvent that are made up into an emulsion (a mixture of oil- and water-based liquids) for injection.
Estonian: Suvaxyn Aujeszky 783 + O/W on pulber ja lahusti süsteemulsiooni (õlil ja veel põhinevate vedelike segu) valmistamiseks.
English: Suvaxyn Aujeszky 783 + O/W was effective at preventing infection with the virus.
Estonian: Suvaxyn Aujeszky 783 + O/W ennetas efektiivselt viirusega nakatumist.
English: Why has Suvaxyn Aujeszky 783 + O/W been approved?
Estonian: Miks Suvaxyn Aujeszky 783 + O/W heaks kiideti?
English: What is Suvaxyn Aujeszky 783 + O/W?
Estonian: Mis on Suvaxyn Aujeszky 783 + O/W?
English: Other information about Suvaxyn Aujeszky 783 + O/W:
Estonian: Muu teave Suvaxyn Aujeszky 783 + O/W kohta
English: How has Suvaxyn Aujeszky 783 + O/W been studied?
Estonian: Kuidas Suvaxyn Aujeszky 783 + O/W efektiivsust uuriti?
English: What is the risk associated with Suvaxyn Aujeszky 783 + O/W?
Estonian: Millised on Suvaxyn Aujeszky 783 + O/W-ga kaasnevad riskid?
English: What is Suvaxyn Aujeszky 783 + O/W used for?
Estonian: Milleks Suvaxyn Aujeszky 783 + O/W-d kasutatakse?
English: How does Suvaxyn Aujeszky 783 + O/W work?
Estonian: Kuidas Suvaxyn Aujeszky 783 + O/W toimib?
English: pregabalin
Estonian: pregabaliin
English: Doses can be increased up to twice more until the most effective dose is reached.
Estonian: Annust võib suurendada kuni kaks korda kuni efektiivseima annuse saavutamiseni.
English: After three to seven days, the dose can be increased to 300 mg per day.
Estonian: Kolme kuni seitsme päeva möödudes võib ravimi ööpäevast annust suurendada 300 mg-ni.
English: Pregabalin Sandoz GmbH is available as capsules (25, 50, 75, 100, 150, 200, 225 and 300 mg) and can only be obtained with a prescription.
Estonian: Ravimit Pregabalin Sandoz GmbH turustatakse kapslitena (25, 50, 75, 100, 150, 200, 225 ja 300 mg) ja see on retseptiravim.
English: The maximum dose is 600 mg per day.
Estonian: 600 mg ööpäevas.
English: Stopping treatment with Pregabalin Sandoz GmbH should also be done gradually, over at least a week.
Estonian: Ka ravi lõpetamine ravimiga Pregabalin Sandoz GmbH peab toimuma järk-järgult, vähemalt nädala jooksul.
English: This reduces the activity of some of the nerve cells in the brain and spinal cord, reducing the release of other neurotransmitters that are involved in epilepsy and anxiety.
Estonian: See vähendab peaaju ja seljaaju närvirakkude elektrilist talitlust, vähendades nii teiste neurotransmitterite vabanemist, mis tekitavad valu, epilepsiat ja ärevust.
English: The full EPAR and risk management plan summary for Pregabalin Sandoz GmbH can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst ja riskijuhtimiskava kokkuvõte Pregabalin Sandoz GmbH kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: A risk management plan has been developed to ensure that Pregabalin Sandoz GmbH is used as safely as possible.
Estonian: Töötati välja riskijuhtimiskava, et tagada Pregabalin Sandoz GmbH võimalikult ohutu kasutamine.
English: What measures are being taken to ensure the safe and effective use of Pregabalin Sandoz GmbH?
Estonian: Mis meetmed võetakse, et tagada Pregabalin Sandoz GmbH ohutu ja efektiivne kasutamine?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pregabalin Sandoz GmbH on 19 June 2015.
Estonian: Euroopa Komisjon andis Pregabalin Sandoz GmbH müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 19. juunil 2015.
English: The active substance in Pregabalin Sandoz GmbH, pregabalin, is similar in structure to the body's own ‘neurotransmitter' gamma‑amino butyric acid (GABA), but has very different biological effects.
Estonian: Pregabalin Sandoz GmbH toimeaine pregabaliin sarnaneb struktuurilt organismi looduslikule neurotransmitterile gamma-aminobutüürhappele (GABA), kuid on teistsuguse bioloogilise toimega.
English: (epileptic fits starting in one specific part of the brain) that cannot be controlled with their current treatment;
Estonian: • epilepsia, mille korral seda ravimit kasutatakse lisaks olemasolevale ravile patsientidel, kelle partsiaalsed (aju teatud osas algavad) epilepsiahood ei ole allunud senisele ravile;
English: Pregabalin Sandoz GmbH is a medicine used to treat adults with the following conditions:
Estonian: Pregabalin Sandoz GmbH on ravim, mida kasutatakse järgmiste haigusseisundite ravimiseks täiskasvanutel:
English: The Committee recommended that Pregabalin Sandoz GmbH be approved for use in the EU.
Estonian: Komitee soovitas Pregabalin Sandoz GmbH kasutamise Euroopa Liidus heaks kiita.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Pregabalin Sandoz GmbH has been shown to have comparable quality and to be bioequivalent to Lyrica.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud Pregabalin Sandoz GmbH võrreldav kvaliteet ja bioekvivalentsus ravimiga Lyrica.
English: Because Pregabalin Sandoz GmbH is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Estonian: Et Pregabalin Sandoz GmbH on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: This means that Pregabalin Sandoz GmbH is similar to a ‘reference medicine' already authorised in the European Union (EU) called Lyrica.
Estonian: See tähendab, et Pregabalin Sandoz GmbH on sarnane võrdlusravimiga Lyrica, millel juba on Euroopa Liidus müügiluba.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Pregabalin Sandoz GmbH, including the appropriate precautions to be followed by healthcare professionals and patients.
Estonian: Selle alusel lisati Pregabalin Sandoz GmbH omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
English: For practical information about using Pregabalin Sandoz GmbH, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate Pregabalin Sandoz GmbH kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: This is a summary of the European public assessment report (EPAR) for Pregabalin Sandoz GmbH.
Estonian: See on ravimi Pregabalin Sandoz GmbH Euroopa avaliku hindamisaruande kokkuvõte.
English: What is Pregabalin Sandoz GmbH and what is it used for?
Estonian: Mis on Pregabalin Sandoz GmbH ja milleks seda kasutatakse?
English: For more information about treatment with Pregabalin Sandoz GmbH, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate ravimiga Pregabalin Sandoz GmbH toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: Because Pregabalin Sandoz GmbH is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica.
Estonian: Et Pregabalin Sandoz GmbH on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati Pregabalin Sandoz GmbH bioekvivalentsust võrdlusravimiga Lyrica.
English: Other information about Pregabalin Sandoz GmbH
Estonian: Muu teave Pregabalin Sandoz GmbH kohta
English: Pregabalin Sandoz GmbH is a ‘generic medicine'.
Estonian: Pregabalin Sandoz GmbH on geneeriline ravim.
English: Pregabalin Sandoz GmbH contains the active substance pregabalin.
Estonian: Pregabalin Sandoz GmbH sisaldab toimeainena pregabaliini.
English: Therefore, the CHMP's view was that, as for Lyrica, the benefit outweighs the identified risk.
Estonian: Seetõttu on inimravimite komitee arvamusel, et nagu ka Lyrica korral, ületab Pregabalin Sandoz GmbH kasulikkus sellega kaasnevad riskid.
English: It is not intended to provide practical advice on how to use Pregabalin Sandoz GmbH.
Estonian: Hindamisaruandes ei anta Pregabalin Sandoz GmbH kasutamise praktilisi nõuandeid.
English: Why is Pregabalin Sandoz GmbH approved?
Estonian: Miks Pregabalin Sandoz GmbH heaks kiideti?
English: How has Pregabalin Sandoz GmbH been studied?
Estonian: Kuidas ravimit Pregabalin Sandoz GmbH uuriti?
English: How does Pregabalin Sandoz GmbH work?
Estonian: Kuidas Pregabalin Sandoz GmbH toimib?
English: How is Pregabalin Sandoz GmbH used?
Estonian: Kuidas ravimit Pregabalin Sandoz GmbH kasutatakse?
English: • 18 months.
Estonian: - 18 kuud.
English: 2003 RN Haarlem The Netherlands
Estonian: 2003 RN Haarlem Holland
English: More severe reactions may occur.
Estonian: Esineda võivad ka palju raskemad reaktsioonid.
English: Your doctor will discuss these with you and will explain the potential risks and benefits of your treatment.
Estonian: Teie arst arutab need teiega läbi ning selgitab teie ravi võimalikke riske ja sellest saadavat kasu.
English: Tell them immediately if you notice any of these effects.
Estonian: Rääkige neile otsekohe, kui te täheldate endal mõnda nendest toimetest.
English: The infusion will last approximately one hour during which you will be in the hospital.
Estonian: Infusioon kestab ligikaudu üks tund, mille ajal te viibite haiglas.
English: Please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Estonian: Palun informeerige oma arsti või apteekrit kui te kasutate või olete hiljuti kasutanud mingeid muid ravimeid, kaasa arvatud ilma retseptita ostetud ravimeid.
English: From a microbiological point of view, the product should be used immediately.
Estonian: Mikrobioloogilisest seisukohast lähtudes tuleb ravim kasutada ära otsekohe.
English: This medicinal product must not be mixed with other medicinal products except those mentioned in Section 6.6.
Estonian: Seda ravimpreparaati ei tohi segada teiste ravimitega, välja arvatud nendega, mis on loetletud lõigus 6.6.
English: Other appropriate symptomatic measures should be taken, as needed.
Estonian: Vajadusel tuleb rakendada muid sümptomaatilisi meetmeid.
English: Statistical Analysis
Estonian: Statistiline analüüs
English: These reactions sometimes appear during the infusion of the medicinal product.
Estonian: Need reaktsioonid tekivad mõnikord ravimi infusiooni ajal.
English: The hospital staff will monitor your condition closely during treatment.
Estonian: Haigla personal jälgib ravi ajal hoolikalt teie seisundit.
English: INFORMATION IN BRAILLE Justification for not including Braille accepted.
Estonian: INFORMATSIOON BRAILLE' KIRJAS (PUNKTKIRJAS) Põhjendus Braille mitte lisamiseks aktsepteeritud.
English: As a result, caution should be exercised when treating patients with these medicinal products as concomitant therapy since there is a potential for a significant interaction.
Estonian: Seetõttu tuleb rakendada ettevaatust, kui patsiente ravitakse samaaegselt nende ravimitega, kuna esineb risk märkimisväärse koostoime tekkeks.
English: If the patient continues to experience these reactions at 60 mg/m², the treatment should be discontinued.
Estonian: Kui patsiendil jätkuvad eespool mainitud reaktsioonid annusega 60 mg/m 2, tuleb ravi katkestada.
English: The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided fro under Article 107c(7) of Directive 2001/83/EC and published on the European Medicines web-portal.
Estonian: Müügiloa hoidja peab esitama asjaomase ravimi perioodilisi ohutusaruandeid kooskõlas direktiivi 2001/83/EÜ artikli 107c punktis 7 sätestatud ja Euroopa ravimite veebiportaalis avaldatud liidu kontrollpäevade loetelu (EURD loetelu) nõuetega.
English: RECOMMENDATIONS FOR THE SAFE HANDLING
Estonian: SOOVITUSED OHUTUKS KÄSITSEMISEKS
English: During these two phase III studies, the safety profile of docetaxel was consistent with the safety profile observed in phase II studies (see section 4.8).
Estonian: Nende kahe III faasi uuringu jooksul oli dotsetakseeli ohutusprofiil kooskõlas II faasi uuringutes täheldatud ohutusprofiiliga (vt lõik 4.8).
English: About 80% of the radioactivity recovered in faeces is excreted during the first 48 hours as one major inactive metabolite and 3 minor inactive metabolites and very low amounts of unchanged medicinal product.
Estonian: Ligikaudu 80% radioaktiivsusest, mis leiti väljaheites, eritub esimese 48 tunniga ühe peamise inaktiivse metaboliidina ja kolme vähemtähtsa inaktiivse metaboliidina ning väga väikses koguses muutumatul kujul.
English: Pharmacotherapeutic group: Taxanes, ATC Code: L01CD 02
Estonian: Farmakoterapeutiline grupp: taksaanid, ATC-kood: L01CD02
English: The overall response rate was 6.8% in the evaluable patients, and the median duration of response was 26.1 weeks.
Estonian: Kogu ravivastuse määr hinnatavate patsientide seas oli 6,8%, keskmine ravivastuse kestus oli 26,1 nädalat.
English: If pregnancy occurs during your treatment, you must immediately inform your doctor.
Estonian: Kui te rasestute ravi ajal, peate te sellest otsekohe oma arsti informeerima.
English: During treatment, you may be given other medicines to maintain the number of your blood cells.
Estonian: Ravi ajal võidakse teile manustada teisi ravimeid, mis aitavad teil säilitada vererakkude arvu.
English: Neuro-motor events are mainly characterised by weakness.
Estonian: Neuromotoorseid nähte iseloomustab enamasti nõrkus.
English: CAUTION: Dilution of concentrate required using the entire contents of the solvent vial.
Estonian: HOIATUS: Kontsentraadi lahjendamisel on vajalik ära kasutada kogu lahusti viaali sisu.
English: In some cases concomitant factors may have contributed to the development of these effects.
Estonian: Mõnedel juhtudel võisid nimetatud toimete teket soodustada muud kaasnevad faktorid.
English: In case of white blood cells disturbances, you may experience associated fever or infections.
Estonian: Valgete verelibledega seotud häirete korral võivad teil tekkida kaasnev palavik või infektsioonid.
English: Pharmacokinetic parameters estimated by the model were very close to those estimated from Phase I studies.
Estonian: Mudeli alusel hinnatud farmakokineetilised parameetrid olid väga lähedased neile, mis leiti I faasi uuringutes.
English: The carcinogenic potential of docetaxel has not been studied.
Estonian: Dotsetakseeli kantserogeenset potentsiaali ei ole uuritud.
English: Dose adjustments during treatment
Estonian: Annuste kohandamine ravi käigus
English: Based on a population pharmacokinetic analysis, there are no special instructions for use in older people.
Estonian: Eakad Populatsiooni farmakokineetilisele analüüsile tuginedes puuduvad erijuhised kasutamiseks eakatel.
English: The peripheral oedema usually starts at the lower extremities and may become generalised with a weight gain of 3 kg or more.
Estonian: Perifeerne turse algab tavaliselt alajäsemetelt ja võib generaliseeruda kehakaalu tõusuga 3 kg võrra või rohkem.
English: Median time to progression (weeks)
Estonian: Keskmine aeg haiguse progressioonini (nädalad)
English: This leaflet was last revised in
Estonian: Infoleht on viimati uuendatud {KK/AAAA}
English: You should usually receive your infusion once every 3 weeks.
Estonian: Manustamissagedus Tavaliselt peaksite te saama ühe infusiooni iga 3 nädala järel.
English: G-CSF was used for secondary prophylaxis in 19.3% of patients (10.7% of the cycles).
Estonian: G-CSF-i kasutati sekundaarseks profülaktikaks 19,3% patsientidel (10,7% tsüklitest).
English: Frequencies are defined as: very common (≥1/10), common (≥1/100 to < 1/10); uncommon (≥1/1,000 to < 1/100); rare (≥1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from the available data).
Estonian: Esinemissagedused on määratletud järgmiselt: väga sage (≥1/10); sage (≥1/100 kuni <1/10); aeg-ajalt (≥1/1000 kuni <1/100); harv (≥1/10 000 kuni <1/1000); väga harv (<1/10 000); teadmata (ei saa hinnata olemasolevate andmete alusel).